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AbstrACt
Objective Identify how individuals involved in developing 
complex health and healthcare interventions (developers), 
and wider stakeholders in the endeavour, such as funders, 
define successful intervention development and what 
factors influence how interventions are developed.
Design In-depth interviews with developers and wider 
stakeholders to explore their views and experiences of 
developing complex health and healthcare interventions.
setting Interviews conducted with individuals in the UK, 
Europe and North America.
Participants Twenty-one individuals were interviewed: 
15 developers and 6 wider stakeholders. Seventeen 
participants were UK based.
results Most participants defined successful intervention 
development as a process that resulted in effective 
interventions that were relevant, acceptable and could 
be implemented in real-world contexts. Accounts also 
indicated that participants aimed to develop interventions 
that end users wanted, and to undertake a development 
process that was methodologically rigorous and provided 
research evidence for journal publications and future 
grant applications. Participants’ ambitions to develop 
interventions that had real-world impact drove them 
to consider the intervention’s feasibility and long-term 
sustainability early in the development process. However, 
this process was also driven by other factors: the 
realities of resource-limited health contexts; prespecified 
research funder priorities; a reluctance to deviate from 
grant application protocols to incorporate evidence and 
knowledge acquired during the development process; 
limited funding to develop interventions and the need 
for future randomised controlled trials (RCTs) to prove 
effectiveness. Participants expressed concern that 
these drivers discouraged long-term thinking and the 
development of innovative interventions, and prioritised 
evaluation over development and future implementation.
Conclusions Tensions exist between developers’ goal of 
developing interventions that improve health in the real 
world, current funding structures, the limited resources 
within healthcare contexts, and the dominance of the 
RCT for evaluation of these interventions. There is a need 
to review funding processes and expectations of gold 
standard evaluation.
bACkgrOunD
In 2008, the UK Medical Research 
Council (MRC) published guidance on how 
to develop and evaluate complex interven-
tions.1 Since then researchers have detailed 
different approaches to intervention develop-
ment,2–4 and a recent review of this literature 
identified 8 categories of approaches and 
18 actions undertaken within them.5 Other 
reviews have detailed how researchers have 
developed interventions in practice,6 7 yet 
concerns have been expressed that too many 
strengths and limitations of this study
 ► Interviews were held with developers and wider 
stakeholders who varied in terms of their disci-
plinary backgrounds, seniority and role in develop-
ing interventions.
 ► The open, flexible nature of the interviews enabled 
participants to raise issues that were salient to them.
 ► The interviews were conducted by an experienced 
researcher who familiarised herself with each par-
ticipant’s work prior to interview, allowing her to ask 
relevant questions.
 ► While aiming to secure an international sample of 
participants, this proved difficult and only four in-
terviews were conducted with individuals not living 
in the UK.
 ► To maintain confidentiality and anonymity, prior to 
data analysis interviews were anonymised and de-
tails of interventions, research studies, contexts and 
individuals removed. This may have reduced the 
richness of the data.
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interventions are not found to be effective or are not 
implemented in the real world.8 
This lack of effectiveness and implementation might be 
because despite increasing amounts of guidance on how 
to develop interventions, research to date has not discov-
ered which approaches or specific actions are essential to 
develop interventions that will improve health outcomes. 
For example, systematic reviews of published approaches 
to intervention development have concluded there is 
a lack of evidence to determine their value in terms of 
future effectiveness. This is the case for co-produced 
or co-designed interventions,9 10 and for intervention 
mapping.11 There is some evidence that the use of theory 
within intervention development leads to effective inter-
ventions,12 but there are also concerns that the relation-
ship between theory use and effectiveness is weak,13 and 
a recent review of reviews concluded that theory-based 
health interventions were not more effective than 
non-theory-based interventions.14
With uncertainty around which approaches to, or 
actions in, the intervention development process lead 
to success, researchers involved in developing complex 
interventions decide for themselves what the focus and 
content of their development process should be. Under-
standing how they define successful intervention devel-
opment and what drives the decisions they make, could 
indicate their priorities and intentions, and subsequently 
provide new insights into why some interventions fail 
to have impact in the real world. It would also indicate 
how they define success and therefore what outcomes 
they think different actions in the development process 
should address. To date, the research that has considered 
the value of different approaches to, or actions within, 
intervention development has focused on the effective-
ness of the interventions produced, but researchers may 
have other definitions of success they are working towards. 
They may, for example, judge the development process 
according to how it is undertaken, as well as against the 
impact of the resulting intervention.
The MRC-National Institute for Health 
Research (NIHR) funded a study to produce guidance 
on intervention development: IdentifyiNg and assessing 
different approaches to DEveloping compleX interven-
tions (INDEX).15 As part of this study, in-depth interviews 
were held with individuals developing interventions and 
wider stakeholders. This paper aims to detail how those 
interviewed defined successful development and the 
factors they viewed as driving the development process.
MethODs
Overall design
The design was a qualitative interview study of individuals 
who had developed complex interventions to improve 
health (ie, developers) and wider stakeholders. Wider 
stakeholders were individuals responsible for or affected 
by health-related and healthcare-related decisions that 
may be informed by research evidence, for example, 
funding panel members, and patient and public involve-
ment (PPI) members. The study was pragmatic in nature 
and used the fact that employing a qualitative method 
would enable attention to be given to context and 
processes, and for participants to describe their views and 
experiences in detail.16
The overall purpose of the interviews was to gain detailed 
insight into the challenges of developing complex health 
and healthcare interventions. The INDEX study they 
were part of, consisted of a systematic methods overview 
of different approaches to intervention development,5 a 
review of journal articles reporting intervention develop-
ment for specific studies, the qualitative interview study 
reported here, and a Delphi consensus exercise that the 
reviews and interviews fed into.
Throughout the INDEX study, the focus was on the 
development of complex interventions that could be deliv-
ered in public health, primary, secondary or social care 
settings. These interventions could include behaviour 
change interventions and interventions directed at health 
providers, patients and policy makers. It did not focus on 
medicines or invasive interventions, for example, pills or 
devices.
Patient and public involvement
PPI members were invited to an expert panel meeting 
held at the start of the INDEX study, and to a consensus 
conference held once the Delphi results were known. 
None attended the first meeting, but PPI members did 
attend the consensus conference aimed at interpreting 
the Delphi results. All study participants will be sent 
copies of journal publications resulting from the INDEX 
study.
recruitment and sampling
For the qualitative interview study, we identified poten-
tial participants through various routes: the results of 
the two reviews conducted as part of the INDEX study, 
members of the INDEX project international expert 
panel, our personal knowledge of individuals working 
in health research and on funding panels, looking at 
funding websites and asking individuals interviewed to 
suggest others we might want to approach. Having iden-
tified potential participants, we purposefully sampled17 
individuals to obtain maximum diversity within our 
sample according to role within the development team 
(lead, co-applicant, stakeholder), professional back-
ground (clinical including medical, nursing and allied 
health professionals, social scientists, others), geograph-
ical location (UK, other European countries, North 
America), intervention type (eg, behaviour change, 
e-health, complex care packages) and setting (primary 
care, secondary care, public health and social care). We 
also aimed for diversity in terms of level of experience, 
sampling individuals who had completed just one inter-
vention development, through to those who had contrib-
uted to multiple developments.
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Data collection
Potential participants were approached by email with 
an attached information sheet. The information sheet 
provided further details about the qualitative study, what 
participation would entail and included a copy of the 
consent form that would be completed prior to inter-
view. The sheet also informed individuals that if they 
took part, they would not be named or identifiable in 
any way. Providing anonymity was viewed as important 
because some participants would be well known within 
the research community. Interested participants were 
contacted by NR to arrange a suitable time and mode of 
interview.
All interviews were conducted by NR, who has over 
20 years’ experience of conducting qualitative interview 
studies and evaluating healthcare technologies, but has 
limited experience of intervention development. This 
meant that she had a good understanding of the general 
context but probed on aspects of intervention develop-
ment that might be taken for granted by a more experi-
enced developer.
Before each interview, NR familiarised herself with the 
participant’s published intervention development work, 
so that she could ask relevant questions, and participants 
completed the consent form (verbally for telephone/
Skype and written for face-to-face). After each interview, 
NR made reflective field notes to assist with analysis.
A topic guide was used to ensure key areas were covered, 
while the open, flexible nature of the interview process 
allowed participants to raise issues that were personally 
salient. The guide was informed by the overall aim of 
the qualitative study and early findings from the INDEX 
systematic review of approaches to intervention develop-
ment.5 Key areas covered by the guide included partic-
ipants’ use of intervention development approaches, 
their experience of developing interventions, how they 
had developed and evaluated specific interventions, and 
what guidance and advice they would give to researchers 
undertaking this process. Initially, the guide did not 
include specific questions about how successful interven-
tion development should be defined, and what factors 
shaped and drove the development process, but analysis 
of the first few interviews indicated definitions of success 
and drivers were important themes in the data. Thus, 
after the first few interviews, the following questions were 
inserted into the guide: "I’m interested in what counts as 
success in the context of intervention development. Do 
you think of this development study, as a successful study? 
Why?; Were there any key aims or principles guiding the 
development of the intervention? What and why?"
Early on during data collection, the importance of main-
taining participant anonymity was confirmed; one person 
reviewed their transcript and asked for a small amount 
of text to be deleted, another person asked during the 
interview for specific comments to be ‘off the record’. 
Following these interviews, the team took the decision 
that only NR would know who had been interviewed.
Data analysis
All the interviews were audio-recorded, then transcribed 
verbatim by an external transcribing service, and checked 
and anonymised by NR. NR removed details of individ-
uals, places and interventions before sharing transcripts 
with other team members.
The data were analysed thematically,18 so that compar-
isons could be made within and across the interviews, 
and participants’ views of specific issues highlighted, for 
example, how individuals identified the need for a new 
intervention. To do this, a coding frame was drafted, 
tested and refined. NR (social scientist), PH (Academic 
General Practitioner), KMT (social scientist) and ED 
(health service researcher and allied health professional) 
independently read three transcripts and constructed 
a coding frame. They then discussed their coding and 
combined their coding frames into a single framework. 
Each of them then applied this framework to two new 
transcripts from interviews conducted at different times 
in the data collection process. Another discussion was 
then held which resulted in the addition of further codes, 
and the deletion or clarification of some existing ones. 
The framework was then finalised, and applied by NR to 
transcripts using NVivo 11 software.19 Each member of 
the team applied the final coding frame independently to 
one transcript; the aim of this exercise was not to establish 
inter-rater reliability as all subsequent coding using this 
framework was conducted by NR, but to allow compar-
ison of, and reflection on, differences.
The framework applied by NR included the code ‘defi-
nitions of success’ and other codes that were relevant 
to the aims of this paper, for example, development 
pathway, study end point, evaluating complex interven-
tions. NR, KMT and PH read data under these codes and 
discussed themes they had identified. As the framework 
NR applied had not been developed with the specific 
aims of this paper in mind, following these discussions 
KMT re-read all the transcripts to check whether there 
were other relevant themes which needed to be captured. 
This also helped her contextualise and fully understand 
comments made. The re-reading of these transcripts led 
to KMT developing a few more codes, for example, indi-
cators of success, actions needed, tensions. These codes 
were added to the framework used by NR and applied 
by KMT where appropriate. Data coded under them 
were then discussed with NR and PH. Using an approach 
based on framework analysis,20 data relevant to this paper 
were summarised in a table formatted so that the rows 
represented each participant and columns relevant 
codes. KMT then read and re-read the table’s content, 
reading down each column in order to identify similar-
ities and differences between the views and experiences 
of different participants in relation to a specific code or 
theme, and across the columns to consider what might 
have influenced each participant’s views and experiences.
Throughout the analysis phase, the emerging analysis 
was discussed at regular team meetings (NR, PH, KMT 
and ED) and with AO'C. At these meetings, NR and KMT 
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detailed their insights and interpretation of the data, 
inviting other team members to comment in light of the 
aims of the analysis and their knowledge of the data and 
literature on intervention development. Data collection 
ceased when no new themes were being identified or 
significantly elaborated, that is, when data saturation21 
had been reached.
FinDings
the participants
The interviews were conducted between February 2017 
and January 2018. Twenty-nine individuals were invited 
for interview and 21 agreed (table 1). Most of those who 
did not respond to the invitation were outside the UK.
Six of the 21 participants interviewed were wider stake-
holders. Three of these stakeholders were funding panel 
members, two were PPI members and the remaining 
stakeholder worked in health service implementation. 
In terms of the remaining participants, that is, the devel-
opers, eight had led intervention development, four as 
‘senior leads’ and four as early career researchers. Some of 
the senior leads had contributed to over 20 development 
projects. However, experience was about number of inter-
ventions completed and about the size and complexity 
of these interventions. Senior leads had typically been 
responsible for developing highly complex interven-
tions that would need considerable health service buy-in 
to implement, and had developed these interventions 
in the context of large scale, £1 million plus (or equiva-
lent in other currencies) research funding. Early career 
researchers had typically completed smaller scale devel-
opments as part of a doctoral or postdoctoral fellowship. 
Participants who had developed the most interventions 
typically had specialist skills, for example, product design 
or behavioural science.
Except for one participant who had developed an inter-
vention mainly on their own, participants had worked 
within a team, and most participants had held various 
roles across different intervention developments (eg, 
lead on one, co-investigator on another). Only two partic-
ipants (both on research funding panels) had no direct 
experience of developing interventions. Between them, 
participants had experience of a wide range of interven-
tion development approaches, including theory based, 
partnership, target population-centred and combined 
approaches.5
Seventeen of the interviews were conducted by tele-
phone, two by Skype (with video) and two (both PPI 
contributors) on a face-to-face basis. They lasted, on 
average, 1 hour.
Overview of findings
Findings are detailed below under two main headings: 
‘successful intervention development’ and ‘drivers of 
intervention development’. This structure reflects the 
aims of the paper, but these sections relate and overlap, as 
some drivers reflected participants’ definitions of success, 
and developers’ views of success could drive the develop-
ment process.
successful intervention development
Participants’ definitions of successful intervention devel-
opment related both to the characteristics of the resulting 
intervention, and to how they thought the actual devel-
opment process should be undertaken. The definitions 
they gave suggested they thought about short-term, medi-
um-term and long-term goals, all of which they might 
consider from the start of the development process but for 
which evidence to indicate they had been achieved would 
come at different time points in the future (figure 1).
Characteristics of the resulting intervention
Most participants talked about aiming to develop effec-
tive interventions. Effective interventions were defined 
as those that reduced the prevalence, incidence or the 
implications of a health condition; improved public and 
patient understanding, treatment outcomes and the 
quality and delivery of care and care systems; and reduced 
healthcare costs by being more cost-effective than current 
care, ensuring more appropriate referrals or reducing 
unnecessary treatments. Yet participants also talked 
about wanting to develop interventions that were rele-
vant to current care systems, health contexts and policies; 
acceptable to practitioners, populations, patients and 
individuals who commissioned healthcare, and feasible to 
deliver in resource-limited health and social care systems 
(UK participants only). Developing an intervention that 
was not practically or financially feasible was described as 
wasting public money:
If somebody says to me, I want to train two educators, I want 
to deliver to 20 patients over a year, I go, ‘well that's very 
nice, so when you’ve got a real plan come back, because this 
is public money’. Very conscious of that. We're very conscious 
about being in there for the long term because there is an 
Table 1 Participants’ details (n=21)
Number
Disciplinary background 
Clinician (doctors, nurses, allied health, 
public health) 
10 
Other (health psychologist, health 
economists, sociologists, product design) 
9 
Patient 2 
Country 
UK 17 
Other parts of Europe 2 
North America 2
Gender 
Female 13 
Male 8
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investment. (Interviewee 11, wider stakeholder, health 
service implementation)
While a few participants mentioned that some 
researchers wanted to demonstrate the effectiveness of 
their interventions before thinking about how they would 
be implemented on a large scale, most commented that 
it was important to think about long-term sustainability 
right from the start of the development process. In addi-
tion, several participants mentioned that transferability 
and scalability of the intervention to different care systems 
and cultures also needed to be considered early on. Yet, 
despite this focus on ensuring potential widespread use, 
one participant made the point that an intervention 
could be viewed as worthwhile if it changed thinking in 
relation to a health issue, even if it was not widely imple-
mented or kept in its original form.
I don't think it (the intervention) was adopted widely … I 
don't know why… perhaps it was because hospitals are so 
busy crisis managing. I think the success has probably been is 
that a lot of other hospitals looked at (the intervention) and 
thought we can adapt this… it's been adapted and rippled 
out… So it's acted as a game changer in the fact that it's 
changed the way other people will look at (the health condi-
tion)… that's how I think (the intervention) would be the 
most effective. (Interviewee 1, wider stakeholder, PPI)
As well as judging whether the development process 
had been successful according to the intervention’s future 
outcomes and impact, a few participants made comments 
that indicated successful intervention development could 
also be defined as one where the resulting intervention 
met the needs and expectations of others. For example, 
one participant who was particularly interested in real 
world implementation of proven interventions, defined 
successful development as one that resulted in an inter-
vention which reflected what patients and practitioners 
needed and wanted. This definition was clearly linked to 
his other definition of success, which was to develop inter-
ventions that were ‘useful, appropriate, acceptable, applicable 
and scalable within practice settings’ (interviewee 4, wider 
stakeholder, funding panel member), in that he believed 
if it did not meet the needs of these individuals, it would 
not be implemented or used. Other participants also 
made this point.
A well-conducted research process
Some participants commented that the development 
process should be a robust piece of research that was 
methodologically strong and incorporated existing 
evidence and stakeholders’ views. One of these partic-
ipants argued that it was important to demonstrate a 
robust process alongside developing interventions that 
were clinically relevant, and that these different measures 
of success were not conflicting.
I think the other thing is ensuring that the idea, the research, 
has clinical credence, that it’s going to be useful… And I 
don’t think the different ways of measuring success, the clin-
ical way of measuring success - patients are better, patients 
are happy, they accept intervention. The academic measures 
of success with academic colleagues are that it has to be ro-
bust, and it shows we know what we’re doing and we get 
support from the (funding) board. I think if people sit down 
Figure 1 Definitions of success.
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and understand that those two different aims aren’t conflict-
ing, which I don’t think they are—they shouldn’t be—then it 
can work nicely. (Interviewee 8, developer)
Lastly, a couple of participants, one who was a very 
experienced developer and the other less experienced, 
commented that a successful development process would 
also produce research evidence on which to base journal 
publications and secure future research funding.
Drivers of intervention development
Some participants described how their development 
processes had been driven by a single factor, while 
others had been shaped by multiple drivers operating at 
different levels or at different times during the develop-
ment process. These drivers could be organised under 
five main headings: developers’ ambitions; existing health 
contexts, care and legislation; research evidence, theories 
and methods; securing funding and the need to evaluate 
using randomised controlled trials (RCTs).
Developers’ ambitions to improve health outcomes
When detailing where the initial idea for an intervention 
had come from, developers described how they had iden-
tified through their work a specific health or healthcare 
issue they wanted to improve. It was clear this ambition to 
improve a situation had been their motivation to develop 
the intervention, and that the issue they had identified 
had driven the intervention’s focus.
What I’m really interested in, it’s about how we get really, re-
ally good evidence-based medicine and access to those services 
for socially marginalised groups… which de facto means 
complex interventions… (Interviewee 14, developer)
This aim of wanting to make a difference fits with the 
aim of developing effective interventions for real-world 
contexts, which in turn requires attention to be given to 
the context in which interventions will be used, making 
health contexts another driver.
Existing health contexts, care and legislation
Participants explained that they needed to develop inter-
ventions that were feasible and affordable to deliver 
within populations, and within existing health contexts, 
practices and systems. Some participants also talked 
about needing to secure support from individuals who 
would be delivering the intervention, or from managers 
or purchasers of care who could prevent it from being 
provided. As participants working in the UK talked about 
practitioners not having the time and resources to do 
more, it did seem that the need to consider the realities 
of health contexts and secure support from others, meant 
developers had to limit how resource-intense their inter-
ventions could be.
… what you see often in both medicine and therapies, they 
have a fantastic approach delivered, but it takes an hour 
more than your clinic slot allows, and therefore it won’t 
be adopted because it’s just not practical or financially 
feasible… to be clinically credible is important, but also I 
knew that management and the commissioners (of care) 
would never countenance it, would never allow it to happen, 
if it was going to cost and take three times as long as normal. 
(Interviewee 8, developer)
It was apparent that existing care and legislations could 
also drive what the intervention would be, again by indi-
cating what would be considered possible and acceptable.
So (the intervention) is recommendation-based models of care 
that are implemented in all (European country) hospitals or 
almost all (European country) hospitals. And it’s part of the 
legislation that was introduced in 2007. (Interviewee 15, 
developer)
Yet alongside this need to consider health contexts, 
accounts suggested that during the development process, 
attention also needed to be given to academic or research 
contexts. It seemed that developers looked to health 
contexts to ensure their interventions were relevant and 
acceptable, but to research evidence, theory and methods 
to ensure their effectiveness.
Research evidence, theories and methods
Most participants described how the content and struc-
ture of their interventions had been informed through 
published evidence, which had indicated areas and issues 
requiring careful consideration to ensure future effec-
tiveness. A few participants also talked about using theo-
ries to gain a deeper understanding of an issue and to 
guide their choice of intervention components. Choice 
of components could also be based on the participant’s 
previous research, and again selected with the aim of 
enhancing the intervention’s potential effectiveness.
The way our intervention was developed was we had some 
initial ideas based on some of our, I'll say, effectiveness work 
on single components or a few components before… we put 
a number of things together. (Interviewee 18, developer)
The use of existing evidence, theories and historical 
experience meant that key components of an inter-
vention were agreed from the start of the development 
process. Alternatively, reviewing existing evidence could 
be part of the development work, and could result in the 
intervention being developed in ways that had not been 
initially predicted.
There definitely was a shift, definitely was a shift in the sense 
that the evidence statements, from the reviews that identified 
the behaviour change techniques that were more likely to be 
associated with effectiveness, we wouldn't have known that 
in the bid, so that was a complete unknown, we could've 
supposed what might be the likely candidates from the oth-
er literature but that was definitely new. (Interviewee 2, 
developer)
Similarly, participants talked about how discussions 
with stakeholders, PPI members, topic experts and the 
results of primary research conducted as part of the 
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development study, had also driven the development 
process in new directions. However, in some circum-
stances participants described how they had ignored such 
insights because they believed funders would want them 
to develop the intervention they had prespecified, there 
were not the resources to develop the intervention in the 
new ways suggested, or because the Principal Investigator 
on the study had very fixed ideas about what the interven-
tion should be.
Interviewee: The intervention was always going to be a 
nurse. It didn't matter what we'd found out about what 
people wanted or what was missing, the answer was going 
to be a nurse.
Researcher: So it sounds like this project's been designed 
so that you will do some qualitative research to develop the 
intervention but alongside that there'd already been a prior 
unacknowledged…
Interviewee: Well I suppose it's acknowledged cause it was 
in the bid…That I think is the other big problem you have 
to specify your intervention in the bid, you know what it is. 
(Interviewee 21, developer)
Very few participants talked about using a formal 
approach to intervention development. Some individ-
uals did mention using the MRC framework,1 but this 
was described as not providing enough detail to guide 
the development process or paying enough attention to 
implementation.
Securing funding to develop interventions
Several participants, including those who were on funding 
panels, commented there was more funding available to 
evaluate interventions than to develop them, and little or 
no funding to facilitate implementation of interventions.
The way developers applied for funding created further 
perceived barriers around successful development. Partic-
ipants explained that researchers usually needed to apply 
to different funders, for individual pots of money, to 
fund different stages of the development and evaluation 
process. Although one participant argued this approach 
gave flexibility which probably led to a better developed 
intervention, this participant and others explained that 
this situation extended the time between the initial 
idea and real-world implementation, a period in which 
contexts may change, rendering the intervention ineffec-
tive or irrelevant. It also meant team members changed, 
losing valuable knowledge and experience, and could 
stop the development process if funding for the next 
phase was not secured. UK participants described NIHR 
Programme Grants for Applied Research as allowing both 
development and evaluation, but even 5 years of funding 
was viewed as insufficient time to do both.
I think, the model where you get in the one package the fund-
ing where you do your pilot, your feasibility, intervention 
development, and your piloting, and then your trial, and 
you know that, as long as it’s all going well, they’re going to 
keep funding you, is probably the only way to go. But, even 
5 years on a programme grant isn't long enough to do that. 
(Interviewee 13, developer)
Where researchers had secured funding in response 
to commissioned calls, that is, calls where the funder 
had specified the research question to be addressed, or 
known the priority areas of a funder, this had determined 
the focus of their intervention. It was also apparent that 
funders could dictate what the intervention should be, 
and funding briefs determine what the development 
process entailed and what needed to be delivered.
(the intervention) was a thing the (government) wanted… 
and we implemented it. (Interviewee 5, developer)
We knew we had to start some iterative pilot testing… and 
we knew that we had to try to get to a phase of something 
that was testable because the mandate from our funder. 
(Interviewee 18, developer)
When describing the process of writing grant applica-
tions, developers talked about playing it safe and aiming 
to develop interventions that the funders could relate 
to, rather than interventions that were innovative and 
required new ways of thinking. In addition, although 
funding board members interviewed said there was flex-
ibility in terms of the extent to which the potential inter-
vention needed to be defined in the grant application, 
one developer described how she felt she had needed to 
specify the intervention and the development process, 
even though this was unrealistic.
Researcher: So are you saying that it would have been okay 
to have said, ‘we think some sort of technology in the home?’
Interviewee: Would have never got funded. It had to be 
reified, specific, and we had to be able to say, ‘it’s this gadget, 
this soft(ware)…’ I had to be all rational… normative… 
All that stuff that you pretend is true when you put in a 
proposal… it’s a figment of everybody’s imagination, it’s 
created… The only places that work like that are nuclear 
power stations, aeroplanes, and a few other things, because 
you’ve got a controlled environment. Yeah. Unless you have 
a controlled environment, ideas of linear, normative plan-
ning are ridiculous. (Interviewee 5, developer)
The need to evaluate using RCTs
Participants talked about public health and healthcare 
practitioners, and purchasers of healthcare services, 
wanting RCT-based evidence that demonstrated the 
intervention’s effectiveness and cost-effectiveness before 
they were willing to support or purchase it. This meant 
developers felt a need to develop interventions that could 
be evaluated within a RCT. Several participants viewed 
this as problematic, explaining that they felt there was a 
tension between developing interventions that were suit-
able for use in the real world and developing interven-
tions that could be evaluated in an RCT. It was argued, for 
example, that the more testable an intervention, the less 
real it became, and that protocolising an intervention for 
research purposes reduced its practicality. Thus, this drive 
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for evidence could work against the goal of developing 
useful real-world interventions.
The work you have to do to turn the intervention into some-
thing that’s testable. Which of course, the more you turn it 
into something that can be subject to an evaluation, the less 
real it becomes, so its characteristics become more specific 
rather than generic. (Interviewee 5, developer)
It needed to be flexible enough to meet the patient’s needs. 
But, having a very strict protocol… although it makes it 
more scientifically credible, isn’t practically deliverable in a 
clinic setting. (Interviewee 8, developer)
Two participants described the MRC framework as 
encouraging the push to develop interventions that 
could be evaluated within RCTs. They described it as 
‘detailing the different phases you go through to create a trial 
of a complex intervention… it is all about how do you create a 
complex intervention trial’ (Interviewee 5, developer) and 
as being focused on ‘you should do that RCT’ (Interviewee 
15, developer).
DisCussiOn
Principal findings
Developers and wider stakeholders defined successful 
intervention development as a rigorous, scientific process 
that resulted in effective interventions that could be 
implemented in real-world contexts. The drivers that 
shaped how interventions were developed indicated 
tensions arose when trying to meet the needs of existing 
structures. Developers targeted areas where change could 
result in better health outcomes. Research evidence and 
theory informed the content, structure and delivery of 
interventions to increase the likelihood of them being 
effective. The characteristics of health contexts also 
shaped the structure and content of the interventions 
developed, although here the drive was mainly to ensure 
they would be acceptable and feasible to deliver. Yet, 
as UK participants talked about how resource limited 
these health contexts could be, this driver also encour-
aged developers to be pragmatic and realistic in their 
designs, developing interventions that were not innova-
tive or resource-intense, possibly reducing their potential 
effectiveness. Perceived requirements of funding bodies 
also discouraged innovation, and the reliance on RCTs 
to prove effectiveness worked against the need for real-
world relevance.
strengths and weaknesses of the study
The in-depth and flexible nature of the interviews with 
a diverse sample of intervention developers and stake-
holders allowed participants to describe, in detail, issues 
important to them. However, we struggled to recruit 
individuals living outside the UK which could limit the 
generalisability of our findings, particularly in rela-
tion to funding and healthcare context, although there 
did not appear to be any clear differences between the 
views of our UK and international participants about the 
development process. The need to maintain anonymity 
promised to each participant did mean details of indi-
viduals, places and interventions needed to be removed 
prior to data analysis. This might have reduced the rich-
ness of the data but, based on reactions of some partici-
pants, anonymity encouraged individuals to talk openly 
about their experiences.
strengths and weaknesses in relation to other studies
To our knowledge, this is the first study to explore devel-
opers’ views of successful intervention development, 
although definitions of success have been implied within 
the literature by researchers aiming to improve the devel-
opment process. For example, Bleijenberg et al22 have 
proposed a development approach that ‘gives devel-
opers a better chance of producing an intervention that 
is well-adopted, fits its context, is effective and ready for 
piloting and trialling’, (p. 92); a statement which echoes 
the main definition of success detailed here.
The importance of integrating health and research 
contexts early on, and considering future implementa-
tion and sustainability, are acknowledged as important in 
the development literature.23–25 However, little is known 
about how many new interventions move on to formal 
piloting, definitive testing and then implementation into 
practice.26 The current evidence suggests the number 
is low,8 overconfidence prevails and a range of biases 
operate.26 Many developers still view RCTs as the only way 
to evaluate an intervention, but this view is being chal-
lenged as researchers acknowledge other methods could 
be used to assess effectiveness and causality.27
Hoddinott26 comments that UK funding bodies have 
not prioritised intervention development. Inadequate 
development of an intervention reduces the likelihood 
of it having an affect,28 and optimising the development 
of complex interventions prior to their evaluation is a way 
to reduce research waste.22 The process of developing 
interventions might be improved if developers used 
guidance provided by formal intervention development 
approaches.5 Our participants seldom mentioned such 
approaches, and this lack of engagement might reflect 
the lack of evidence about which ones lead to success.
implications for practice and future research
The findings of the INDEX study, along with the revised 
version of the MRC guidance on developing and evalua-
tion complex interventions due to be published in 2019, 
should support developers in reflecting on and hopefully 
achieving successful intervention development. However, 
the process of determining what needs to be done will 
remain unclear until researchers provide evidence that 
demonstrates what actions lead to interventions that 
improve health. This should be a priority area for future 
research. In addition, funders need to consider giving 
more funding to intervention development research and 
how funding processes can better support innovation and 
long-term planning.
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